Stock Price
2.17
Daily Change
-0.18 -7.66%
Monthly
-3.98%
Yearly
69.53%
Q2 Forecast
2.06

Galectin Therapeutics reported $1.27M in Interest Expense on Debt for its fiscal quarter ending in June of 2024.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Bristol-Myers Squibb USD 411M 21M Mar/2026
Galectin Therapeutics USD 1.27M 220K Jun/2024
Gilead Sciences USD 240M 15M Mar/2026
Immunic 197K 222K Dec/2025
Incyte USD 569K 13K Mar/2026
Merck USD 479M 67M Mar/2026